Journal Club – Bruxelles Heart Group

Home
Current Fellows
Journal Club

Digoxin and Mortality in Patients with Atrial Fibrillation

Device Related Thrombosis after Percutaneous Left Atrial Appendge Acclusion for Atrial Fibrillation

Outcomes after Angiography with Sodium Bicarbonate & Acetylcysteine

Catheter Ablation for Atrial Fibrillation with Heart Failure

Effectiveness of Rescue Percutaneous Balloon Aortic Valvuloplasty in patients with Severe Aortic Stenosis & Acute Heart Failure

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients

Dobutamine Stress Echocardiography for Management of Low Flow-Low Gradient Aortic Stenosis

Early Arrythmic Events in Idiopathic Dilated Cardiomyopathy

Diagnostic Accuracy of Angiography- Based Quantitative Flow Ratio Measurements

Permanent His- bundle pacing for cardiac resynchronization therapy: Initial feasibility study in lieu of left ventricular lead

PCI strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

Does use of Bilateral Internal Mammary Artery Grafting Reduce Long Term Risk of Repeat Coronary Revascularization

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

Prognostic Value of Serial ST2 Measurements in Patients with Acute Heart Failure

Oral Anticoagulation, Aspirin, or No Therapy in Patients with Nonvalvular AF with 0 or 1 Stroke Risk

Catheter Ablation vs. Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction

Percutaneous coronary intervention in stable angima (ORBITA): a double-blind, randomised controlled trial

Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy vs. Isolated Coronary Artery Bypass Grafting

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

Long Term Outcomes of Patient Foramen Ovale Closure or Medical Therapy after Stroke

Pulmonary Artery Pressure- Guided Mgmt. of Patients with Heart Failure and Reduced Ejection Fraction

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Effect of ranolazine on atrial fibrillation in patients with non ST elevation acute coronary syndromes

Oxygen Therapy in Suspected Acute Myocardial Infarction

Ranolazine in Patients with incomplete Revascularisation after Percutaneous Coronary Intervention (RIVER-PCI)

Threshholds for Ambulatory Blood Pressure among African Americans in the Jackson Heart Study

Withholding versus Continuing Angiotensin converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Non-cardiac Surgery

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI

Time to Furosemide Treatment and Mortality in Patients Hospitalized with Acute Heart Failure

Antithrombotic Therapy and First Myocardial Infarction in Patients with Atrial Fibrillation

B-Blockers & Mortality After Acute Myocardial Infarction
Outcomes in Patients with Chest Pain Discharged After Evaluation
Surgical Transcatheter Aortic Valve Replacement in Intermediate Risk Patients

Fractional Flow Reserve in PCI
Ventricular Tachycardia Ablation Versus Medical Therapy
Treatment Options for Acute MI

B Blockers and Mortality After Myocardial Infarctin in Patients Without Heart Failure
Bariatric Surgery and the Risk of New Onset Atrial Fibrillation
Body Weight Change During and After Hospitalization for Acute Heart Failure
Cardio Risk Factor Mgmt Performance in Canada and the US
Complete or Culprit Only Revascularization
CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
Diastolic Blood Pressure, Subclinical Myocardial Damage and Cardiac Events
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
Evolocumab and Clinical outcomes in patients with Cardio Disease
Interaction between Spironolactone and Natriuretic Peptides
Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias
Long Term Outcomes in Patients with Aortic Regurgitation
Low-Dose Aspirin for Primary Prevention of Cardio Events in Patients with Type 2 Diabetes Mellitus
Metabolic effects of Carvediolol vs Metoprolol in Patients With Type 2 Diabetes
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
Prevention of cardiac dysfunction during adjuvant breast cancer therapy PRADA
Transcatheter Mitral Valve Replacement for Patients with Symptomatic Mitral Regurgitation